Key result
In adult congenital heart disease patients, the presence of severe valvular heart disease was independently associated with an increased risk of cardiovascular mortality and hospitalization (HR 1.925).
Why the study?
Does the presence of severe valvular heart disease increase the risk of cardiac mortality and unplanned cardiac hospitalization in adult congenital heart disease patients?
Observational (n=390)
No
Does the presence of severe valvular heart disease increase the risk of cardiac mortality and unplanned cardiac hospitalization in adult congenital heart disease patients?
Hazard Ratio: 1.925 (95% CI 1.133–3.271)
p-value: p=0.015
Severe valvular heart disease is an independent predictor of cardiac mortality and unplanned hospitalization in adult congenital heart disease patients, providing incremental prognostic value.
May aid ACHD risk stratification; leaves open whether valvular intervention alters outcomes.
Background: The clinical impact of valvular heart disease (VHD) in adult congenital heart disease (ACHD) patients is unascertained. Aim of our study was to assess the prevalence and clinical impact of severe VHD (S-VHD) in a real-world contemporary cohort of ACHD patients. Materials and methods: Consecutive patients followed-up at our ACHD Outpatient Clinic from September 2014 to February 2021 were enrolled. Clinical characteristics and echocardiographic data were prospectively entered into a digitalized medical records database. VHD at the first evaluation was assessed and graded according to VHD guidelines. Clinical data at follow-up were collected. The study endpoint was the occurrence of cardiac mortality and/or unplanned cardiac hospitalization during follow-up. Results: = 0.017) to a multivariate model including age, severe CHD, atrial fibrillation, %Sat O2, NYHA, LVEF, and right ventricle systolic pressure > 45 mmHg. Conclusion: In ACHD patients, the presence of S-VHD is independently associated with the occurrence of cardiovascular mortality and hospitalization. The prognostic value of S-VHD is incremental above other established prognostic markers.
No takes yet. Share an insight, caveat, or question.
Graziani et al. (2022) conducted an observational in Adult congenital heart disease (ACHD) (n=390). Severe valvular heart disease vs. Non-severe valvular heart disease was evaluated on Composite of cardiac death and/or cardiac hospitalization (HR 1.925, 95% CI 1.133-3.271, p=0.015). In adult congenital heart disease patients, the presence of severe valvular heart disease was independently associated with an increased risk of cardiovascular mortality and hospitalization (HR 1.925).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: